You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

mass. movers

Vertex Pharmaceuticals to join S&P 500

Jeffrey Leiden is Vertex’s CEO and president.

Essdras M Suarez/Globe Staff

Jeffrey Leiden is Vertex’s CEO and president.

Continue reading below

Vertex Pharmaceuticals is one of two companies that will join the S&P 500, along with Ametek Inc., a Pennsylvania electronic instruments firm. The pair will switch spots with AMD Inc. and SAIC Inc., which will join the MidCap 400. S&P said the moves will better align the businesses with indices more representative of their market capitalizations. Both Vertex and Ametek have market caps of more than $10 billion, the S&P said. The switch will take place after trading closes Sept. 20.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com